Q1 2022 Holdings
Filed 2022-05-16 | 24 holdings | $148.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $78.6M | 2,489,974 | 53.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $25.9M | 761,398 | 17.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $23.0M | 2,267,486 | 15.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $12.0M | 178,500 | 8.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $8.3M | 658,266 | 5.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $118.9K | 2,340,059 | 0.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $23.7K | 1,566,895 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $22.2K | 2,563,138 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $22.2K | 1,356,250 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $18.5K | 340,214 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $17.1K | 813,456 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $17.0K | 1,049,691 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $14.5K | 450,776 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $13.5K | 575,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $10.5K | 100,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.1K | 1,475,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $6.8K | 2,300,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $5.9K | 321,641 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.1K | 525,284 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $5.0K | 55,800 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $3.0K | 80,000 | 0.0% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $1.1K | 176,470 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $845 | 279,921 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $616 | 149,400 | 0.0% |